HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of orally administered low dose N-methanocarbathymidine against lethal herpes simplex virus type-2 infections of mice.

AbstractBACKGROUND:
N-methanocarbathymidine (N-MCT) has previously been shown to be effective against lethal orthopoxvirus and herpes simplex virus type-1 infections in mice. In this investigation, the antiviral activity of N-MCT was assessed against herpes simplex virus type-2 (HSV-2) in BALB/c mice.
METHODS:
BALB/c mice were infected intranasally with a lethal challenge dose of HSV-2. N-MCT was administered orally twice daily to mice using doses of 0.01 to 100 mg/kg to determine effects on survival and on viral replication in organ and central nervous system (CNS) samples.
RESULTS:
N-MCT provided significant protection from mortality even when treatments were delayed until 3 days after viral infection. Viral replication in organ and CNS samples from N-MCT-treated mice was reduced below the limit of detection after 4 days of treatment.
CONCLUSIONS:
These results indicated that low dose N-MCT treatment was more effective than acyclovir therapy. N-MCT may be effective against HSV disease in humans and is currently undergoing preclinical evaluation. In particular, its potential use as a combination therapy for HSV, with its differing metabolism from acyclovir, make it a promising compound to develop for human use.
AuthorsDebra C Quenelle, Deborah J Collins, Terri L Rice, Aquilur Rahman, Robert Glazer
JournalAntiviral chemistry & chemotherapy (Antivir Chem Chemother) Vol. 22 Issue 3 Pg. 131-7 (Nov 17 2011) ISSN: 2040-2066 [Electronic] England
PMID22095521 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antiviral Agents
  • (north)-methanocarbathymidine
  • Thymidine
Topics
  • Administration, Oral
  • Animals
  • Antiviral Agents (administration & dosage, pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Herpes Simplex (drug therapy, virology)
  • Herpesvirus 2, Human (drug effects)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Survival Rate
  • Thymidine (administration & dosage, analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: